INTRODUCTION
============

Secondary hemorrhage after hysterectomy is a rare but life-threatening complication that may require prompt medical and surgical intervention. Although the overall incidence of secondary hemorrhage is low, gynecologists do come across secondary hemorrhage of varying degrees of severity.^[@B1]^ A few studies have shown the overall incidence of hemorrhage to be 0.2% and 2% after hysterectomy, which includes reactionary and secondary hemorrhage.^[@B1][@B2][@B4]^ Our center has been performing laparoscopic hysterectomies since 1994, and we have encountered 1 or 2 cases of secondary hemorrhage per year in the second or third postoperative week that necessitates hospitalization and active treatment. We believe this incidence is higher after laparoscopic hysterectomy than after the other modes of hysterectomy.

The purpose of this study is to estimate the cumulative incidence of secondary hemorrhage resulting after laparoscopic hysterectomy. The second goals of this study are to describe the patient characteristics of those with secondary hemorrhage after hysterectomy and to identify the potential risk factors.

MATERIALS AND METHODS
=====================

All women who underwent total laparoscopic hysterectomy (TLH) performed by the first author at Paul\'s Hospital between January 2004 and April 2012 were included in this study. The medical records of the patients were reviewed to ensure that those patients who had bleeding per vaginam between 24 hours and 6 weeks after primary surgery and those requiring some intervention in the form of vaginal packing, vault suturing, laparoscopy, laparotomy, or embolization procedures were included in the analysis.

The institutional review board approved the data collection, aggregation, and analysis for this project. The following data were studied: age, parity, body mass index, indication for hysterectomy, size of uterus, details of surgical procedure, administration of antibiotics, time interval between hysterectomy and secondary hemorrhage presenting symptoms, hemodynamic status, and type of intervention needed to manage secondary hemorrhage.

TLH procedures were performed by dissecting the entire uterus laparoscopically; the uterine arteries were coagulated with a bipolar method or Enseal (Ethicon Endo-Surgery, Somerville, New Jersey); and laparoscopic culdotomy was performed with a monopolar hook with a 60-W cutting current at a level above the uterosacral attachment, preserving the uterosacral arch. Additional hemostasis was achieved with bipolar forceps. Specimens were removed vaginally after morcellation with a knife and without undue traction. The vaginal cuff was closed vaginally in a continuous nonlocking fashion vertically or in transverse fashion with No. 1-0 Polysorb (Covidien, Mansfield, MA, USA), Vicryl (Ethicon Endo-Surgery), or Dexon (Covidien, Mansfield, MA, USA). The vault was inspected laparoscopically at the end of the procedure and complete hemostasis ensured. All patients received 2 doses of antibiotics, the first dose intraoperatively and the second dose postoperatively, and they were discharged on postoperative day 1. Statistical analyses were performed with the χ^2^ test, Kruskal-Wallis test, and analysis of variance. *P* \< .05 was considered statistically significant.

RESULTS
=======

A total of 1613 patients underwent TLH during the study period, and 21 patients had secondary hemorrhage after hysterectomy. The overall cumulative incidence of secondary hemorrhage after TLH was 1.3%. The annual cumulative incidence of secondary hemorrhage after TLH was also analyzed **([Table 1](#T1){ref-type="table"})**. Patient characteristics and clinical presentation were reviewed **([Table 2](#T2){ref-type="table"})**.

###### 

Overall and Annual Cumulative Incidence of Secondary Hemorrhage After TLH

                                                     2004   2005   2006   2007   2008   2009   2010   2011   January to April 2012   Total
  -------------------------------------------------- ------ ------ ------ ------ ------ ------ ------ ------ ----------------------- -------
  No. with secondary hemorrhage                      3      3      3      2      3      4      2      1      0                       21
  Total No. with TLH                                 127    193    248    203    143    208    193    209    89                      1613
  Cumulative incidence of secondary hemorrhage (%)   2.36   1.55   1.21   0.99   2.10   1.92   1.04   0.48   0.00                    1.30

###### 

Demographic Characteristics of Patients With Secondary Hemorrhage After Total Laparoscopic Hysterectomy

  Variable                                            Patients With Hemorrhage (n = 21)   Patients Without Hemorrhage (n = 1592)   *P* Value
  --------------------------------------------------- ----------------------------------- ---------------------------------------- -----------
  Age (mean ± SD) (y)                                 45.8 ± 4.5                          46.3 ± 6.1                               .7
  Parity                                                                                                                           
      0                                               0                                   66 (4.1%)                                
      1                                               4 (19%)                             284 (17.8%)                              .5
      ≥2                                              17 (81%)                            1236 (77.6%)                             
  Mode of delivery                                                                                                                 
      Vaginal                                         15 (71.4%)                          1101 (69.2%)                             .5
      Cesarean                                        6 (28.6%)                           415 (26.1%)                              
  BMI^[a](#TF2-1){ref-type="table-fn"}^ (mean ± SD)   27.22 ± 3.7                         27.02 ± 4.7                              .8

BMI = body mass index.

The indications for the hysterectomies are shown in **[Table 3](#T3){ref-type="table"}**, with the main indication being myoma uterus in both groups. Surgical details of patients are described in **[Table 4](#T4){ref-type="table"}**. The mean size of the uterus was 541.4 g in the secondary hemorrhage group and 318.9 g in patients without hemorrhage, which was statistically significant. The mean duration of surgery was 100.7 minutes and the mean blood loss was 266.7 mL in patients with secondary hemorrhage, which were greater than those in the patients without hemorrhage but not statistically significant. In patients with hemorrhage after TLH, a bipolar cautery was used in 14 cases and Enseal was used to coagulate the uterine pedicle in the remaining 7 patients. The vagina was closed transversely in 10 patients and vertically in 11 patients. The suture material used for vault suturing was Dexon, Vicryl, and Polysorb in 6, 8, and 7 patients, respectively, in the group with secondary hemorrhage. The median time interval between hysterectomy and secondary hemorrhage was 13 days.

###### 

Indications for Hysterectomy

                                       Hemorrhage Group   Nonhemorrhage Group
  ------------------------------------ ------------------ ---------------------
  Indication                           15 (71.4%)         1000 (62.8%)
      Myoma                                               
      Cervical pathology               0                  14 (0.86%)
      Myoma and endometriosis          2 (9.5%)           112 (7.0%)
      Myoma and ovarian pathology      1 (4.8%)           28 (1.8%)
      Adenomyosis                      1 (4.8%)           163 (10.3%)
      Dysfunctional Uterine Bleeding   1 (4.8%)           76 (4.8%)
      Endometrial hyperplasia          0                  20 (1.3%)
      Ovarian pathology                0                  52 (3.3%)
      Postmenopausal bleeding          1 (4.8%)           64 (4.0%)
      Uterine prolapse                 0                  7 (0.4%)
  Total                                21                 1592

###### 

Surgical Details

                                                         Hemorrhage Group (n = 21)   Nonhemorrhage Group (n = 1592)   *P* Value
  ------------------------------------------------------ --------------------------- -------------------------------- ---------------------------------------
  Previous laparotomy                                                                                                 
      No                                                 16                          1147                             
      Yes                                                05                          445                              .5
  Energy source of uterine artery                                                                                     
      Bipolar                                            14                          900                              
      Enseal                                             7                           692                              .4
  Technique of vault suturing                                                                                         
      Transverse                                         11                          771                              
      Vertical                                           10                          821                              .7
  Type of suture material                                                                                             
      Dexon                                              6                           322                              
      Vicryl                                             8                           824                              .43
      Polysorb                                           7                           446                              
  Duration of surgery (mean ± SD) (min)                  100.7 ± 24.5                85.2 ± 38.6                      .07
  Estimated blood loss during surgery (mean ± SD) (mL)   266.7 ± 92.6                228.5 ± 125.4                    .2
  Weight of uterus (mean ± SD) (g)                       541.4 ± 444.5               318.9 ± 258.4                    .04^[a](#TF4-1){ref-type="table-fn"}^

Statistically significant.

All patients presented with bleeding per vaginam of varying degrees **([Table 5](#T5){ref-type="table"})**. The amount of bleeding was mild in 10 cases and severe (\>200 mL) in 11 cases. Along with bleeding, 2 patients had a fever and 1 patient had a cough. Three patients were in a state of hypovolemic shock at the time of hospitalization. Blood transfusions were needed in 5 patients.

###### 

Clinical Presentation and Treatment of Secondary Hemorrhage

  Symptoms/Treatment                               No. of Patients With Secondary Hemorrhage
  ------------------------------------------------ -------------------------------------------
  Associated symptoms                              
      Fever                                        2
      Cough                                        1
  Severity of hemorrhage                           
      Mild ≤200 mL                                 10
      Profuse \>200 mL                             11
  Hemodynamic status                               
      Stable                                       20
      Shock                                        3
  Treatment                                        
      Blood transfusion                            5
      Vaginal packing                              13
      Vault suturing                               6
      Laparoscopic coagulation of uterine artery   1
      Uterine artery embolization                  1

For the management of secondary hemorrhage, vaginal packing was sufficient to control bleeding in 13 patients whereas 6 patients required vault suturing. Laparoscopic coagulation of the uterine artery was performed in 1 patient, in whom the source of bleeding could not be identified vaginally. Uterine artery embolization was performed twice in 1 patient to control the bleeding. Resumption of sexual intercourse was not found in any of these patients because all of them presented within 6 weeks after surgery. The period of abstinence advised after TLH was 6 to 8 weeks.

DISCUSSION
==========

Hemorrhage after hysterectomy is a rare but life-threatening complication.^[@B1]^ In our study, 21 patients (1.3%) had secondary hemorrhage among 1613 hysterectomies. There are few published reports of the incidence of secondary hemorrhage after hysterectomy. Holub and Jabor^[@B4]^ reported 2 cases (0.17%) of secondary hemorrhage in their series of 1167 patients with laparoscopic hysterectomy and vaginal hysterectomy. Wilke et al^[@B1]^ reported an incidence of secondary hemorrhage of 0.23% after vaginal hysterectomy and laparoscopic hysterectomy. In an earlier study by Bhattacharya et al,^[@B3]^ the incidence of secondary hemorrhage was 0.45% after vaginal hysterectomies.

The cumulative incidence of secondary hemorrhage is higher in our study than the incidence in the previous studies. An infrequent occurrence of secondary hemorrhage, failure to report to the center where hysterectomy was performed, or nondocumentation of cases may be the possible reason for the lower incidences reported in the literature. Possible factors that may play a role in secondary hemorrhage are vaginal vault infection, vault hematoma, poor surgical technique including excessive thermal injury by electrocoagulation, and early resumption of physical activity. Another possible reason for the higher rate of secondary hemorrhage in our study is our technique of preserving the arch of the uterosacral ligaments, which includes more cervical tissue and may have a greater chance of bleeding.

TLH is a feasible and safe technique in cases of enlarged uteri, which permits avoidance of laparotomy with evident benefits for the patients.^[@B5]^ The size of the uterus was significantly higher among patients in the secondary hemorrhage group. High vascularity and large-sized vessels may be responsible for the increased incidence of secondary hemorrhage in large-sized uteri.

The source of bleeding in secondary hemorrhage can be from the uterine vessels or descending cervical/vaginal vessels. Because the source of bleeding was from the uterine vessels in only 2 cases in our study, it appears that the use of an energy source for the uterine vessels is unlikely to increase the incidence of secondary hemorrhage after TLH. Occasionally, uterine artery pseudoaneurysm can cause delayed heavy vaginal bleeding after laparoscopic hysterectomy.^[@B6]^

Monopolar energy was used for culdotomy in all patients in the TLH group. The use of thermal energy may result in increased tissue damage to the vaginal cuff.^[@B2]^ Vault bleeding was responsible for secondary hemorrhage in 19 of 21 cases. Hence the use of an energy source for the vault may be responsible for the higher incidence of secondary hemorrhage after TLH. It may be advisable to minimize the use of thermal energy so that the tissue is not overdesiccated.^[@B2]^

The technique of vaginal vault closure may also contribute to the occurrence of secondary hemorrhage. Reich^[@B7]^ recommends laparoscopic vaginal vault closure with McCall culdeplasty for good support of the vaginal vault. The first suture brings the uterosacral ligaments, cardinal ligament, and posterior vaginal fascia together across the midline. The rest of the vagina and overlying pubocervicovesicular fascia are closed vertically with 1 or 2 No. 0 Vicryl interrupted sutures. However, in our study the vaginal cuff was closed vaginally in a continuous nonlocking fashion vertically or in transverse fashion with No. 1-0 Polysorb, Vicryl, or Dexon. The vault was inspected laparoscopically at the end of the procedure, and complete hemostasis was ensured. In a study by Uccella et al,^[@B6]^ the rate of postoperative vaginal bleeding was lower after transvaginal cuff closure than after laparoscopic cuff suturing. There was less need for vaginal cuff resuturing when transvaginal closure was performed compared with laparoscopic closure.

The time interval between hysterectomy and the onset of secondary hemorrhage ranged between 3 and 22 days. For the few reported cases in the literature, the time interval varied from 3 to 18 days.^[@B1],[@B2],[@B4]^

In our study we have used vaginal packing to control secondary hemorrhage occurring from the vaginal cuff. Vaginal packing should be tight enough to stop the bleeding, although it is unpleasant for the patient without anesthesia. In the initial few cases we examined the patient while under short-lasting general anesthesia after packing to determine whether the bleeding had completely stopped. Later, we found it unnecessary if the pack was dry and discontinued this practice. The pack was usually removed after 24 hours. Most patients could be treated with vaginal packing alone, and this finding implies that the source of bleeding could be from the vaginal cuff. Any active bleeding that cannot be controlled by packing can be secured with suture. In another study the vaginal cuff bleeding in 3 cases was managed by vaginal repair and packing without laparoscopic re-exploration or transfusion.^[@B4]^ Laparoscopic surgery in patients with postoperative bleeding after hysterectomy is feasible and may be recommended if the source of bleeding cannot be identified by vaginal examination or if the symptoms indicate that the source of bleeding is intra-abdominal.^[@B4]^ Laparoscopy provides good magnification, which allows closer inspection, as well as a more precise use of bipolar coagulation or suturing for management of hemorrhage.^[@B1]^ In our study, one patient underwent laparoscopic coagulation of the uterine artery after TLH. Emergency therapeutic arterial embolization is a safe and effective minimally invasive procedure for patients in whom postoperative hemorrhage develops after gynecologic laparoscopic surgery.^[@B9]^ In our study, one patient with secondary hemorrhage in the TLH group underwent uterine artery embolization twice. Vaginal vault dehiscence is one of the rare complications after hysterectomy.^[@B10]^ In our study, we did not come across any cases of vaginal vault dehiscence. Minimal use of diathermy on the vault and the technique of vaginal suturing, which included the pericervical tissue, may be the reason for the nonoccurrence of vault dehiscence.

The exact cause for increased incidence of secondary hemorrhage after TLH is unknown. We may hypothesize that the application of thermal energy to tissues may cause more tissue necrosis and devascularization than sharp culdotomy in abdominal and vaginal hysterectomies. Treatment of secondary hemorrhage through the vaginal approach in the form of packing, suturing, and drainage of hematoma appears to be feasible as an initial intervention to control bleeding. In addition, care must be taken while performing TLH in large uteri and limiting the overly enthusiastic use of thermal energy. TLH is still recommended over abdominal hysterectomy because of the obvious advantages.^[@B10][@B11][@B12]^

The limitation of this study is that it is a retrospective observational study. Further prospective randomized controlled trials are needed to validate our results.

CONCLUSION
==========

Our data suggest that secondary hemorrhage is rare but may occur more often after TLH than after other hysterectomy approaches. The comparison of different energy sources such as ultrasonic or bipolar methods with scissors for culdotomy in TLH is worth studying. A large uterus size, excessive use of an energy source for the uterine artery, and culdotomy may play a role.
